Online citations, reference lists, and bibliographies.

Management Of Patients With Atrial Fibrillation.

Andrew D. Beaser, Adam S. Cifu
Published 2019 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1056/NEJMoa1009638
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
Manesh R Patel (2011)
10.1016/j.jacc.2019.01.011
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
Craig T. January (2019)
10.1056/NEJMoa1107039
Apixaban versus warfarin in patients with atrial fibrillation.
Christopher B. Granger (2011)
10.1016/j.jacc.2015.04.025
Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis.
David R. Holmes (2015)
10.1093/eurheartj/ehu367
Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation.
Riccardo Cappato (2014)
10.1093/eurheartj/ehy148
Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial
Michael D. Ezekowitz (2018)
10.1056/NEJMoa1310907
Edoxaban versus warfarin in patients with atrial fibrillation.
Robert P Giugliano (2013)
10.1016/S0140-6736(16)31474-X
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
Andreas Goette (2016)
10.1056/NEJMoa1707855
Catheter Ablation for Atrial Fibrillation with Heart Failure
Nassir F. Marrouche (2018)
10.1056/NEJMoa0905561
Dabigatran versus warfarin in patients with atrial fibrillation.
Stuart J. Connolly (2009)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar